Quarterly report pursuant to Section 13 or 15(d)

Warrant Liability

v3.2.0.727
Warrant Liability
6 Months Ended
Jun. 30, 2015
Warrant Liability [Abstract]  
Warrant Liability Disclosure [Text Block]
7. Warrant Liability
 
On April 9, 2012, in connection with subscription agreements with certain institutional investors for the purchase and sale of 6,517,648 shares of our common stock, we issued (i) six-year warrants (“Series A Warrants”) to purchase 6,517,648 shares of common stock at an exercise price of $1.15 per share and (ii) six-month warrants (“Series B Warrants”) to purchase 6,517,648 shares of common stock at an exercise price of $0.85 per share. As a result of our public offering in October 2014 and anti-dilution provisions contained in the outstanding Series A warrants, the exercise price of such warrants was reduced from $1.15 to $0.89 per share. The Series A Warrants and Series B Warrants contain a provision where the warrant holder has the option to receive cash, equal to the Black Scholes fair value of the remaining unexercised portion of the warrant, as cash settlement in the event that there is a fundamental transaction (contractually defined to include various merger, acquisition or stock transfer activities). Due to this provision, ASC 480, Distinguishing Liabilities from Equity requires that these warrants be classified as liabilities. The fair values of these warrants have been determined using the Lattice valuation model, and the changes in the fair value are recorded in the Statements of Operations and Comprehensive Loss. The Lattice model provides for assumptions regarding volatility and risk-free interest rates within the total period to maturity.
 
During the year ended December 31, 2012, Series B Warrants to purchase 5,761,765 shares of common stock were exercised at a price of $0.85 per share. The remaining Series B Warrants to purchase 755,883 shares of common stock expired in October 2012.
 
During the year ended December 31, 2013, Series A Warrants to purchase 1,109,010 shares of common stock were exercised resulting in gross proceeds of approximately $1,275,000. The remaining Series A Warrants to purchase 5,408,638 shares of common stock will expire in April 2018.
 
The key assumptions used to value the Series A Warrants were as follows:
 
 
 
June 30,
 
Assumption
 
2015
 
Expected price volatility
 
 
90
%
Expected term (in years)
 
 
2.8
 
Risk-free interest rate
 
 
0.93
%
Dividend yield
 
 
0.00
%
Weighted-average fair value of warrants
 
$
0.31
 
   
In October 2014, we completed an underwritten public offering (the “2014 Offering”) of 21,000,000 units at an offering price of $0.50 per unit, with each unit consisting of one share of common stock and 0.75 of a warrant (“Class A Warrant”), each full warrant to purchase one share of common stock at an exercise price of $0.60 per share. The Class A Warrants will entitle the holders thereof to purchase an aggregate of 15,750,000 shares of our common stock at an initial exercise price of $0.60 per share of common stock. The Class A Warrants will be exercisable beginning on the later of (i) one year and one day from the date of issuance and (ii) the date our stockholders approve either an increase in the number of our authorized shares of common stock or a reverse stock split, in either case in an amount sufficient to permit the exercise in full of the Class A Warrants and will expire on the fifth anniversary of the date they first become exercisable.
 
We agreed to hold a stockholders meeting no later than March 31, 2015 in order to seek stockholder approval for an amendment to our certificate of incorporation to either (i) increase the number of shares of common stock we are authorized to issue or (ii) effect a reverse split of the common stock, in either case in an amount sufficient to permit the exercise in full of the Class A Warrants in accordance with their terms. In the event that we are unable to effect an increase in our authorized shares of common stock or effect a reverse split of our common stock prior to October 9, 2015, we will be required to pay liquidated damages in the aggregate amount of $2,500,000. In February 2015, the Class A Warrants were amended to extend the date of the required stockholders’ meeting to August 31, 2015.
 
We also agreed to issue to the underwriter warrants to purchase 630,000 shares of common stock (the “Underwriter Warrants”). The Underwriter Warrants have an exercise price per share of $0.60 and may be exercised on a cashless basis. The Underwriter Warrants are not redeemable by us. The Underwriter Warrants are substantially the same form as the Class A Warrants included in the units except that they do not include certain liquidated damages rights contained in the Class A Warrants and will expire on the fifth anniversary of the date of effectiveness of the registration statement.
 
At the time these warrants were issued, we did not have adequate authorized and unissued common shares to be able to satisfy the exercise of these warrants. ASC 480, Distinguishing Liabilities from Equity requires that these warrants be classified as liabilities. The fair values of these warrants have been determined using the Binomial Lattice (“Lattice”) valuation model, and the changes in the fair value are recorded in the Statements of Operations and Comprehensive Income (Loss). The Lattice model provides for assumptions regarding volatility and risk-free interest rates within the total period to maturity.
 
The key assumptions used to value the Class A Warrants were as follows:
 
 
 
June 30,
 
Assumption
 
2015
 
Expected price volatility
 
 
90
%
Expected term (in years)
 
 
5.3
 
Risk-free interest rate
 
 
1.67
%
Dividend yield
 
 
0.00
%
Weighted-average fair value of warrants
 
$
0.51
 
  
The key assumptions used to value the Underwriter Warrants were as follows:
 
 
 
June 30,
 
Assumption
 
2015
 
Expected price volatility
 
 
90
%
Expected term (in years)
 
 
4.3
 
Risk-free interest rate
 
 
1.40
%
Dividend yield
 
 
0.00
%
Weighted-average fair value of warrants
 
$
0.45